MarketPulse

nuclear medicine

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Precedence Research

Radiopharmaceuticals Market to Double to $15.21B by 2035 Amid Cancer Surge

Global radiopharmaceuticals market projected to grow from $8.28B (2026) to $15.21B (2035) amid rising cancer and cardiovascular disease incidence.
LLYCAHNVSLNTHSIEGY+1cancer treatmentradiopharmaceuticals
The Motley FoolThe Motley Fool··James Halley

Telix Pharmaceuticals Eyes Growth With Nuclear Medicine Expansion

Telix Pharmaceuticals expands its nuclear medicine presence with approved cancer-targeting drugs and 56% revenue growth, positioning itself as a key player in oncology diagnostics and therapeutics.
TLXbiotechradiopharmaceuticals